Development of ATP13A2-deficient In vitro Model for PARK9 Parkinson’s Disease
Conclusion: ATP13A2-deficient PD model was successfully developed.
Source: Current Signal Transduction Therapy - Category: Molecular Biology Source Type: research
More News: Brain | Calcium | Chloride | Genetics | Molecular Biology | Nanotechnology | Neuroblastoma | Neurology | Study